Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis
Situ M, Schwarz UI, Zou G, McArthur E, Kim RB, Garg AX, Sarma S. Eur J Health Econ. 2023; May 17 [Epub ahead of print].